Lion Point Capital, LP Portfolio Holdings

Lion Point Capital, LP

  • $10.5 Million
  • Q3 2025

Lion Point Capital, LP has filed its 13F form on November 14, 2025 for Q3 2025 where it was disclosed a total value porftolio of $10.5 Million distributed in 27 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Milestone Pharmaceuticals Inc. with a value of $1.31M, Fennec Pharmaceuticals Inc. with a value of $1.13M, Insmed Inc with a value of $900K, Ardelyx, Inc. with a value of $898K, and Syndax Pharmaceuticals Inc with a value of $846K.

Examining the 13F form we can see an increase of $1.64M in the current position value, from $8.91M to 10.5M.

Lion Point Capital, LP is based out at New York, NY

Below you can find more details about Lion Point Capital, LP portfolio as well as his latest detailed transactions.

Portfolio value $10.5 Million
Healthcare: $10.5 Million

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$61.8M
$1.31 Million 12.43% of portfolio
658,553
Q3 2025 Added 20.0%
$211M
$1.13 Million 10.73% of portfolio
123,000
Q3 2025 Reduced 37.15%
$26.2B
$900,000 8.54% of portfolio
6,250
Q3 2025 Reduced 41.31%
$908M
$898,000 8.52% of portfolio
162,750
Q3 2025 Reduced 51.48%
$940M
$846,000 8.03% of portfolio
55,000
Q4 2024 Added 19.05%
$17.1B
$754,000 7.15% of portfolio
21,400
Q3 2025 New
$9.84B
$690,000 6.55% of portfolio
13,300
Q3 2025 Reduced 48.85%
$423M
$685,000 6.5% of portfolio
500,000
Q4 2024 Reduced 20.63%
$1.5B
$665,000 6.31% of portfolio
35,300
Q3 2025 Reduced 23.76%
$498M
$557,000 5.28% of portfolio
57,750
Q3 2024 Added 59.31%
$363M
$495,000 4.7% of portfolio
58,000
Q3 2025 New
$472M
$483,000 4.58% of portfolio
67,500
Q3 2025 New
$749M
$407,000 3.86% of portfolio
46,000
Q3 2025 New
$646M
$296,000 2.81% of portfolio
42,000
Q3 2025 New
$231M
$280,000 2.66% of portfolio
86,000
Q3 2025 New
$122M
$145,000 1.38% of portfolio
83,500
Q1 2025 New
Seres Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 59.28%
Spruce Biosciences Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Disc Medicine Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 37.66%
Praxis Precision Medicines I
-
$0 0.0% of portfolio
-
Q3 2025 New
Mineralys Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 50.63%
Benitec Biopharma Inc
-
$0 0.0% of portfolio
-
Q4 2024 Added 58.97%
Mersana Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 New
Kiniksa Pharmaceuticals Intl
-
$0 0.0% of portfolio
-
Q3 2025 Reduced 49.02%
Biohaven LTD
-
$0 0.0% of portfolio
-
Q4 2024 Reduced 35.88%
Jasper Therapeutics Inc
-
$0 0.0% of portfolio
-
Q3 2025 Added 172.05%

Summary

  • Portfolio
  • No. of Stocks 27
  • Current Value $10.5 Million
  • Prior Value $8.91 Million
  • Filing
  • Period Q3 2025
  • Filing Date November 14, 2025
  • Form Type 13F-HR
  • Activity in Q3 2025
  • New Purchases 9 stocks
  • Additional Purchases 3 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 8 stocks
Track This Portfolio

Track Lion Point Capital, LP Portfolio

Follow Lion Point Capital, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lion Point Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lion Point Capital, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email